Novo Nordisk A/S (NVO) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Novo Nordisk A/s Class B.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.274 Good day and thank you for standing by. Welcome to the Q2 2026 00:00:05.274 -- 00:00:09.436 Novo Nordisk A S earnings conference call. 00:00:09.436 -- 00:00:13.318 At this time all participants are in a listen only mode. 00:00:13.318 -- 00:00:17.120 After the speaker's presentation there will be a question and answer session. 00:00:17.120 -- 00:00:22.423 To ask a question during the session you will need to press star 1 and 1 on your telephone. 00:00:22.423 -- 00:00:26.245 You will then hear an automated message advising your hand is raised. 00:00:26.245 -- 00:00:30.088 To withdraw your question please press star 1 and 1 again. 00:00:30.088 -- 00:00:33.450 Please be advised that today's conference is being recorded. 00:00:33.450 -- 00:00:38.514 I would now like to hand the conference over to your speaker today, Michael Novod, 00:00:38.514 -- 00:00:42.876 Head of Investor Relations. Please go ahead. 00:00:43.557 -- 00:00:45.759 Thank you very much, operator. 00:00:45.759 -- 00:00:50.682 Welcome to this NOVA Nordisk earnings call for the second quarter of 2026. 00:00:50.682 -- 00:00:55.025 My name is Michael Novod. I'm the Head of Investor Relations at NOVA Nordisk. 00:00:55.025 -- 00:00:59.815 With me today I have CEO of NOVA Nordisk, Mike Doustdar, 00:00:59.815 -- 00:01:04.879 EVP US Operations Jamey Millar, EVP International Operations 00:01:04.879 -- 00:01:10.203 Emil Kongshøj Larsen, EVP Research and Development and Chief Scientific Officer Martin 00:01:10.203 -- 00:01:15.127 Holst Lange, and Chief Financial Officer Karsten Munk Knudsen. 00:01:15.127 -- 00:01:18.289 All speakers will be available for the Q&A session. 00:01:18.289 -- 00:01:23.033 Today's call is being webcasted live, and a recording will be made available on our ...